UK markets closed

GeoVax Labs, Inc. (GOVX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1500+0.1533 (+15.38%)
At close: 04:00PM EDT
1.1700 +0.02 (+1.74%)
After hours: 07:58PM EDT

GeoVax Labs, Inc.

1900 Lake Park Drive
Suite 380
Smyrna, GA 30080
United States
678 384 7220

Full-time employees11

Key executives

NameTitlePayExercisedYear born
Mr. David Alan DoddChairman, Pres & CEO381.5kN/A1950
Mr. Mark W. Reynolds CPA, CPACFO & Corp. Sec.339.99kN/A1962
Dr. Mark J. Newman Ph.D.Chief Scientific Officer175kN/A1955
Dr. Harriet Latham RobinsonFounder, Chief Scientific Officer Emeritus & Member of Scientific Advisory BoardN/AN/A1938
Dr. Kelly T. McKee Jr., M.D., M.P.H.Chief Medical OfficerN/AN/A1950
Jeffrey WelchHead of Process Devel. & Manufacturing OperationsN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Corporate governance

GeoVax Labs, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.